Icon Plc is a global clinical research organization based in Dublin, Ireland, offering a wide range of services to the pharmaceutical, biotechnology, and medical device industries. The company specializes in managing all stages of the clinical development process, from early compound selection through to Phase I-IV clinical studies. Icon Plc provides comprehensive services including clinical trial management, consulting, laboratory services, and post-market commercialization support. With a focus on innovation, Icon Plc supports its clients in bringing new medicines and treatments to market efficiently and effectively.
Pre-Market Stock Futures: Futures are trading higher this morning, after all the big funds and portfolio managers may have shown their hands on Wednesday, as the tech and chip stocks sell-off resumed…
Citi swept through its life science tools and diagnostics coverage on Wednesday, opening a 90-day upside catalyst watch on Agilent Technologies (NYSE:A | A Price Prediction) while trimming its price target on…
The relentless bull run led by high-flying growth stocks is no longer here, and 2025 has brought a significant shift in the market landscape, with the S&P 500 now in correction territory.…
